Prostate Cancer
First Safety and Efficacy Data with the Radiohybrid 177Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer.
January 4, 2024
Avoiding unnecessary biopsy: the combination of PRIMARY score with prostate-specific antigen density for prostate biopsy decision.
January 4, 2024
In Vitro Prostate Cancer Treatment via CRISPR-Cas9 Gene Editing Facilitated by Polyethyleneimine-Derived Graphene Quantum Dots.
January 2, 2024
Association of neighborhood gentrification with prostate cancer and immune markers in African American and European American men.
January 2, 2024
Validation of schedules for optimal prostate-specific antigen monitoring after radical prostatectomy.
January 2, 2024
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
January 2, 2024